MedPath

Influence of SGLT2-inhibitor (Canagliflozin) in patients with DM who underwent cardiac surgery

Not Applicable
Conditions
patients with diabetes mellitus underwent cardiac surgery
Registration Number
JPRN-UMIN000021239
Lead Sponsor
Sekino Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who were deemed not appropriate to participate in this study by doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath